{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-6293"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-6293","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Antiviral Resistance and Dynamic Treatment and Chemoprophylaxis of Pandemic Influenza","abstract":"Public health data show the tremendous economic and societal impact of pandemic influenza in the past. Currently, the welfare of society is threatened by the lack of planning to ensure an adequate response to a pandemic. This preparation is difficult because the characteristics of the virus that would cause the pandemic are unknown, but primarily because the response requires tools to support decision-making based on scientific methods. The response to the next pandemic influenza will likely include extensive use of antiviral drugs, which will create an unprecedented selective pressure for the emergence of antiviral resistant strains. Nevertheless, the literature has insufficient exhaustive models to simulate the spread and mitigation of pandemic influenza, including infection by an antiviral resistant strain. We are building a large-scale simulation optimization framework for development of dynamic antiviral strategies including treatment of symptomatic cases and chemoprophylaxis of pre- and post-exposure cases. The model considers an oseltamivir-sensitive strain and a resistant strain with low/high fitness cost, induced by the use of the several antiviral measures. The mitigation strategies incorporate age/immunitybased risk groups for treatment and pre-/post-exposure chemoprophylaxis, and duration of pre-exposure chemoprophylaxis. The model is tested on a hypothetical region in Florida, U.S., involving more than one million people. The analysis is conducted under different virus transmissibility and severity scenarios, varying intensity of non-pharmaceutical interventions, measuring the levels of antiviral stockpile availability. The model is intended to support pandemic preparedness and response policy making.","abstract_html":"Public health data show the tremendous economic and societal impact of pandemic influenza in the past. Currently, the welfare of society is threatened by the lack of planning to ensure an adequate response to a pandemic. This preparation is difficult because the characteristics of the virus that would cause the pandemic are unknown, but primarily because the response requires tools to support decision-making based on scientific methods. The response to the next pandemic influenza will likely include extensive use of antiviral drugs, which will create an unprecedented selective pressure for the emergence of antiviral resistant strains. Nevertheless, the literature has insufficient exhaustive models to simulate the spread and mitigation of pandemic influenza, including infection by an antiviral resistant strain. We are building a large-scale simulation optimization framework for development of dynamic antiviral strategies including treatment of symptomatic cases and chemoprophylaxis of pre- and post-exposure cases. The model considers an oseltamivir-sensitive strain and a resistant strain with low/high fitness cost, induced by the use of the several antiviral measures. The mitigation strategies incorporate age/immunitybased risk groups for treatment and pre-/post-exposure chemoprophylaxis, and duration of pre-exposure chemoprophylaxis. The model is tested on a hypothetical region in Florida, U.S., involving more than one million people. The analysis is conducted under different virus transmissibility and severity scenarios, varying intensity of non-pharmaceutical interventions, measuring the levels of antiviral stockpile availability. The model is intended to support pandemic preparedness and response policy making.","abstract_has_math":false,"creators":["Paz, Sandro"],"institution":"University of South Florida","degree_name":null,"degree_level":"Dissertation","degree_discipline":"Industrial and Management Systems Engineering","degree_department":null,"school":null,"contributors":["Alex Savachkin, Ph.D","Heide Castañeda, Ph.D.","Kingsley Reeves, Ph.D.","Alex Volinsky, Ph.D.","Hui Yang, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014-03-21T07:00:00Z","date_published":"2014-03-21T07:00:00Z","updated_at":"2026-11-19T08:42:01Z","subjects":["Antiviral Agent","Computer Simulation","Design of Experiments","Disease Outbreaks","Dynamic Programming","Operational Research","Public Health"],"languages":["EN-US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/5097","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/5097","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-6293","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Alex Savachkin, Ph.D","Heide Castañeda, Ph.D.","Kingsley Reeves, Ph.D.","Alex Volinsky, Ph.D.","Hui Yang, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Paz, Sandro"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2014-03-21T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Industrial and Management Systems Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation","Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Antiviral Agent","Computer Simulation","Design of Experiments","Disease Outbreaks","Dynamic Programming","Operational Research","Public Health"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["EN-US"]},{"key":"dc:rights.license","label":"Dc Rights License","values":["default"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/5097"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Public health data show the tremendous economic and societal impact of pandemic influenza in the past. Currently, the welfare of society is threatened by the lack of planning to ensure an adequate response to a pandemic. This preparation is difficult because the characteristics of the virus that would cause the pandemic are unknown, but primarily because the response requires tools to support decision-making based on scientific methods. The response to the next pandemic influenza will likely include extensive use of antiviral drugs, which will create an unprecedented selective pressure for the emergence of antiviral resistant strains. Nevertheless, the literature has insufficient exhaustive models to simulate the spread and mitigation of pandemic influenza, including infection by an antiviral resistant strain. We are building a large-scale simulation optimization framework for development of dynamic antiviral strategies including treatment of symptomatic cases and chemoprophylaxis of pre- and post-exposure cases. The model considers an oseltamivir-sensitive strain and a resistant strain with low/high fitness cost, induced by the use of the several antiviral measures. The mitigation strategies incorporate age/immunitybased risk groups for treatment and pre-/post-exposure chemoprophylaxis, and duration of pre-exposure chemoprophylaxis. The model is tested on a hypothetical region in Florida, U.S., involving more than one million people. The analysis is conducted under different virus transmissibility and severity scenarios, varying intensity of non-pharmaceutical interventions, measuring the levels of antiviral stockpile availability. The model is intended to support pandemic preparedness and response policy making."]},{"key":"dc:title","label":"Title","values":["Antiviral Resistance and Dynamic Treatment and Chemoprophylaxis of Pandemic Influenza"]}]}],"canonical_facts":{"dc:contributor":["Alex Savachkin, Ph.D","Heide Castañeda, Ph.D.","Kingsley Reeves, Ph.D.","Alex Volinsky, Ph.D.","Hui Yang, Ph.D."],"dc:creator":["Paz, Sandro"],"dc:date":["2014-03-21T07:00:00Z"],"dc:description":["Public health data show the tremendous economic and societal impact of pandemic influenza in the past. Currently, the welfare of society is threatened by the lack of planning to ensure an adequate response to a pandemic. This preparation is difficult because the characteristics of the virus that would cause the pandemic are unknown, but primarily because the response requires tools to support decision-making based on scientific methods. The response to the next pandemic influenza will likely include extensive use of antiviral drugs, which will create an unprecedented selective pressure for the emergence of antiviral resistant strains. Nevertheless, the literature has insufficient exhaustive models to simulate the spread and mitigation of pandemic influenza, including infection by an antiviral resistant strain. We are building a large-scale simulation optimization framework for development of dynamic antiviral strategies including treatment of symptomatic cases and chemoprophylaxis of pre- and post-exposure cases. The model considers an oseltamivir-sensitive strain and a resistant strain with low/high fitness cost, induced by the use of the several antiviral measures. The mitigation strategies incorporate age/immunitybased risk groups for treatment and pre-/post-exposure chemoprophylaxis, and duration of pre-exposure chemoprophylaxis. The model is tested on a hypothetical region in Florida, U.S., involving more than one million people. The analysis is conducted under different virus transmissibility and severity scenarios, varying intensity of non-pharmaceutical interventions, measuring the levels of antiviral stockpile availability. The model is intended to support pandemic preparedness and response policy making."],"dc:identifier":["https://digitalcommons.usf.edu/etd/5097"],"dc:language":["EN-US"],"dc:rights.license":["default"],"dc:subject":["Antiviral Agent","Computer Simulation","Design of Experiments","Disease Outbreaks","Dynamic Programming","Operational Research","Public Health"],"dc:title":["Antiviral Resistance and Dynamic Treatment and Chemoprophylaxis of Pandemic Influenza"],"thesis:degree_discipline":["Industrial and Management Systems Engineering"],"thesis:degree_level":["Dissertation","Ph.D."],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:42:01Z"}